Loss of heterozygosity as a marker to predict progression of oral epithelial dysplasia to oral squamous cell carcinoma.
作者信息
Rao Umadevi Krishna Mohan, Thavarajah Rooban, Joshua Elizabeth, Ranganathan Kannan
机构信息
Department of Oral and Maxillofacial Pathology and Microbiology, Ragas Dental College and Hospitals, Affiliated to the Tamil Nadu Dr. M.G.R. Medical University, Chennai, Tamil Nadu, India. E-mail:
出版信息
J Oral Maxillofac Pathol. 2018 May-Aug;22(2):155-160. doi: 10.4103/jomfp.JOMFP_151_18.
Abstract
摘要
相似文献
1
Loss of heterozygosity as a marker to predict progression of oral epithelial dysplasia to oral squamous cell carcinoma.杂合性缺失作为预测口腔上皮发育异常进展为口腔鳞状细胞癌的标志物。
J Oral Maxillofac Pathol. 2018 May-Aug;22(2):155-160. doi: 10.4103/jomfp.JOMFP_151_18.
2
Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma.口腔上皮异型增生和鳞状细胞癌中 PTEN 的杂合性缺失和免疫表达。
Exp Mol Pathol. 2020 Feb;112:104341. doi: 10.1016/j.yexmp.2019.104341. Epub 2019 Nov 13.
3
Can MMP-9 be a Prognosticator Marker for Oral Squamous Cell Carcinoma?基质金属蛋白酶-9能否作为口腔鳞状细胞癌的预后标志物？
J Clin Diagn Res. 2016 Jan;10(1):ZC09-13. doi: 10.7860/JCDR/2016/14128.7034. Epub 2016 Jan 1.
4
Myofibroblasts as important diagnostic and prognostic indicators of oral squamous cell carcinoma: An immunohistochemical study in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma.肌成纤维细胞作为口腔鳞状细胞癌重要的诊断和预后指标：一项在正常口腔黏膜、上皮发育异常及口腔鳞状细胞癌中的免疫组织化学研究
J Carcinog. 2020 Mar 30;19:1. doi: 10.4103/jcar.JCar_3_20. eCollection 2020.
5
Management of oral epithelial dysplasia: a review.口腔上皮发育异常的管理：综述
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103 Suppl:S19.e1-12. doi: 10.1016/j.tripleo.2006.10.015. Epub 2007 Jan 25.
6
Comparative analysis of cell proliferation ratio in oral lichen planus, epithelial dysplasia and oral squamous cell carcinoma.口腔扁平苔藓、上皮异型增生和口腔鳞状细胞癌中细胞增殖率的比较分析。
Med Oral Patol Oral Cir Bucal. 2009 Nov 1;14(11):e563-7. doi: 10.4317/medoral.14.e563.
7
Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.ELF3 免疫表达缺失有助于检测口腔鳞状细胞癌，但不能用于区分上皮异型增生的程度。
Ann Diagn Pathol. 2013 Aug;17(4):331-40. doi: 10.1016/j.anndiagpath.2013.03.003. Epub 2013 May 3.
8
Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study.人端粒酶逆转录酶蛋白在口腔上皮发育异常及口腔鳞状细胞癌中的表达：一项免疫组织化学研究
J Oral Maxillofac Pathol. 2016 Jan-Apr;20(1):96-101. doi: 10.4103/0973-029X.180953.
9
Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma.口腔上皮异常增生和鳞状细胞癌中假定的癌症干细胞标志物表达。
J Oral Pathol Med. 2013 Nov;42(10):755-60. doi: 10.1111/jop.12073. Epub 2013 Apr 25.
10
[Frequency of oral squamous cell carcinoma and oral epithelial dysplasia in oral and oropharyngeal mucosa in Chile].[智利口腔及口咽黏膜中口腔鳞状细胞癌和口腔上皮发育异常的发生率]
Rev Med Chil. 2016 Feb;144(2):169-74. doi: 10.4067/S0034-98872016000200004.
引用本文的文献
1
Loss of Heterozygosity in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma - A Scoping Review.口腔潜在恶性疾病和口腔鳞状细胞癌中的杂合性缺失——一项范围综述
Head Neck Pathol. 2025 Apr 25;19(1):49. doi: 10.1007/s12105-025-01787-x.
2
Predictive Value of Anti- E6 Oncoprotein (High Risk- Human Papilloma Virus) and p16 Ink4a for Detecting HPV in Oral Epithelial Dysplasia.抗 E6 癌蛋白（高危型人乳头瘤病毒）和 p16 Ink4a 对口腔上皮异型增生中 HPV 检测的预测价值。
Asian Pac J Cancer Prev. 2022 Nov 1;23(11):3915-3922. doi: 10.31557/APJCP.2022.23.11.3915.
3
Oral lichen planus: a microbiologist point of view.口腔扁平苔藓：微生物学家的观点。
Int Microbiol. 2021 Aug;24(3):275-289. doi: 10.1007/s10123-021-00168-y. Epub 2021 Mar 10.
4
The Potential of Phytochemicals in Oral Cancer Prevention and Therapy: A Review of the Evidence.植物化学物在口腔癌预防和治疗中的潜力：证据回顾。
Biomolecules. 2020 Aug 6;10(8):1150. doi: 10.3390/biom10081150.
本文引用的文献
1
Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions.潜在恶性口腔上皮病变的危险因素及发病机制。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):603-611. doi: 10.1016/j.oooo.2018.03.008. Epub 2018 Mar 20.
2
Head and Neck Cancer in the New Era of Precision Medicine.精准医学新时代的头颈癌
J Dent Res. 2018 Jun;97(6):601-602. doi: 10.1177/0022034518772278.
3
Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications.与潜在癌前口腔上皮病变的发生和进展相关的分子标志物：当前认知与未来意义。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):650-669. doi: 10.1016/j.oooo.2018.03.012. Epub 2018 Apr 4.
4
Report of a consensus meeting of a group of oral and general pathologists in India on grading of oral epithelial dysplasia.印度一组口腔及普通病理学家关于口腔上皮发育异常分级的共识会议报告。
Oral Oncol. 2018 Jun;81:109-110. doi: 10.1016/j.oraloncology.2018.03.018. Epub 2018 Apr 11.
5
Precision Therapy of Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌的精准治疗。
J Dent Res. 2018 Jun;97(6):614-621. doi: 10.1177/0022034518769645. Epub 2018 Apr 12.
6
The molecular landscape of head and neck cancer.头颈部癌症的分子图谱。
Nat Rev Cancer. 2018 May;18(5):269-282. doi: 10.1038/nrc.2018.11. Epub 2018 Mar 2.
7
Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine.非吸烟者口腔上皮异型增生的特征：迈向精准医学的第一步。
Oral Oncol. 2018 Mar;78:119-125. doi: 10.1016/j.oraloncology.2018.01.028. Epub 2018 Feb 20.
8
Oral leukoplakia remains a challenging condition.口腔白斑病仍然是一种具有挑战性的疾病。
Oral Dis. 2018 Mar;24(1-2):179-183. doi: 10.1111/odi.12781.
9
Interventions for treating oral leukoplakia to prevent oral cancer.用于治疗口腔白斑以预防口腔癌的干预措施。
Cochrane Database Syst Rev. 2016 Jul 29;7(7):CD001829. doi: 10.1002/14651858.CD001829.pub4.
10
Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, Canada.加拿大不列颠哥伦比亚省利用杂合性缺失管理癌前口腔发育异常的成本效益分析。
Oncologist. 2016 Sep;21(9):1099-106. doi: 10.1634/theoncologist.2015-0433. Epub 2016 Jul 11.
Zotero 插件